Pharmaceutical Preparations · DE · CIK 1709941
Developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 3 sold $6.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $20.30 | $151K |
| Feb 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $18.75 | $139K |
| Jan 13, 2026 | Fortney KristenChief Executive Officer | Sell | 233,107 | $18.12 | $4.2M |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 11,663 | $20.54 | $240K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 8,974 | $18.43 | $165K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 4,440 | $19.45 | $86K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 1,923 | $21.08 | $41K |
| Jan 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $12.85 | $96K |
| Dec 9, 2025 | Rubin Paul DChief Medical Officer | Sell | 18,000 | $12.00 | $216K |
| Dec 4, 2025 | Rubin Paul DChief Medical Officer | Sell | 68,897 | $10.19 | $702K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.